Skip to main content
Caplight Logo









Bindbridge

Bindbridge

Private
CambridgeHealthcare & Life Scienceshttps://bindbridge.com

Last Round

Seed

Mar 3, 2026

Total Funding Raised

$3.8M

Momentum

Top 25%

of companies Caplight tracks

Company Overview

Bindbridge operates in Healthcare & Life Sciences and is based in Cambridge. Its latest recorded funding round was a Seed round in March 2026.

Bindbridge is an ag-biotech company that develops an AI-driven molecular discovery platform to identify molecular glues for crop protection.

Sector

Healthcare & Life Sciences

Verticals

Biotechnology, Drug Discovery

Business Model

B2B

Customer Profile

Data as a Service, Services & Consulting

AI Layer

Application

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Pricing history

Caplight clients see full MarketPrice™ history and secondary transactions.

Book a demo

For institutional investors. Book with your work email.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

Momentum history

Caplight clients track how buyer interest and sentiment change over time.

Book a demo

For institutional investors. Book with your work email.

Bindbridge Comparables

Compare Bindbridge with similar companies based on industry and business-model similarity.

Bindbridge comparables — related companies by embedding similarity
CompanySimilarityMarket Cap
Mycoverse
68%
Ternary Therapeutics
32%
Molecular Glue Labs Ltd
32%
Book a demo to see all comparables

For institutional investors. Book with your work email.

Bindbridge Funding Rounds

Historical fundraising activity

Data table
RoundDateAmount RaisedValuationInvestorsSources
SeedMar 3, 2026
Book a demo to see all funding rounds

For institutional investors. Book with your work email.

Bindbridge Investors

Notable investors and investment history

Bindbridge investors
InvestorRounds
Nucleus CapitalSeed
SpeedinvestSeed

Market signals

Structured signals derived from secondary market and firmographic data.

  • Jul 13, 2026

    Open roles increased to 7, 70% of headcount.

  • Mar 3, 2026

    $4M round led by Nucleus Capital and Speedinvest

Book a demo to see all signals

For institutional investors. Book with your work email.

Bindbridge Filings

Explore SEC and related filing metadata, where available.

Bindbridge filings preview — column headings only; records require access
TypeDateAmount OfferedAmount SoldFilingPagesDownload

Filing documents are not displayed on this public page. Request access to learn about available coverage.

Book a demo

For institutional investors. Book with your work email.

Frequently Asked Questions

Common questions about Bindbridge's valuation, stock price, and market status.

Is Bindbridge a public or private company?

Bindbridge is a private company.

What is the current stock price of Bindbridge?

Bindbridge is a private company, so its shares have no public market price. Caplight tracks Bindbridge's secondary market activity and provides MarketPrice™ estimates of its share price to Caplight users.

How much is Bindbridge worth (valuation)?

Valuation information for Bindbridge is not publicly available.

Can I buy Bindbridge stock?

Bindbridge shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors.

When was Bindbridge's last funding round?

Bindbridge's most recent funding round was Seed on March 3, 2026.

Who are the main investors in Bindbridge?

Key investors in Bindbridge include Nucleus Capital, Speedinvest.

Will Bindbridge IPO soon?

No public IPO plans have been announced for Bindbridge.

How can I track Bindbridge secondary market activity?

Caplight tracks bids, offers, and trades in Bindbridge's shares on secondary markets.

Firmographic Details

HeadquartersCambridge
Employee Range10
Year Founded2025
Last FundingMar 3, 2026

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Book a demo

For institutional investors. Book with your work email.

See something wrong or outdated?